Advanced Chemotherapy Technologies, Inc. Announces $5.5M Series A Financing Round led by Khosla Ventures
Oct 29, 2020•over 4 years ago
Amount Raised
$5 Million
Round Type
series a
Description
Advanced Chemotherapy Technologies, Inc., a clinical-stage drug delivery company, announced today that it has closed a $5.5 million Series A investment round led by Khosla Ventures. The capital will be used to fund initial clinical development of the company’s ACT-IOP-003 local chemotherapy system for the treatment of locally advanced non-resectable and borderline resectable pancreatic cancer.
FundzWatch™ Score
71
Medium Activity
Buyer Intent Analysis
Get personalized insights on buying likelihood